Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0JVBFW
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
DB-2306
|
|||||
| Synonyms |
DB2306; DB 2306
Click to Show/Hide
|
|||||
| Organization |
Duality Biologics
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Indication |
In total 2 Indication(s)
Autoimmune disorder [ICD11:4A41-4A4Z]
Clinical candidate
Immune dysregulation syndrome [ICD11:4A01]
Clinical candidate
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Tumor necrosis factor receptor superfamily member 1A (TNFRSF1A)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Duality Immune Modulating Antibody Conjugate (DIMAC) technology.
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.